Noninvasive prenatal genetic testing (NIPT) is an advance in the detection of fetal
chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant …

Background Common fetal aneuploidies include Down syndrome (trisomy 21 or T21),
Edward syndrome (trisomy 18 or T18), Patau syndrome (trisomy 13 or T13), Turner …

Objective Accurate prenatal diagnosis of genetic conditions can be challenging and usually
requires invasive testing. Here, we demonstrate the potential of next‐generation sequencing …

The present disclosure provides methods for determining the ploidy status of a chromosome
in a gestating fetus from genotypic data measured from a mixed sample of DNA comprising …

The identification of cell-free fetal DNA (cffDNA) in maternal plasma in 1997 heralded the
most significant change in obstetric care for decades, with the advent of safer screening and …

Noninvasive Prenatal Testing Goes Global | Science Translational Medicine news careers
commentary Journals Science Science brought to you byGoogle Indexer Log in science …

Noninvasive prenatal genetic testing (NIPT) for chromosomal aneuploidy involving the
analysis of cell-free fetal DNA became commercially available in 2011. The low false …

Noninvasive prenatal testing (NIPT) using cell‐free DNA is being offered to an increasing
number of women. Comprehensive pre‐test counseling is complicated by emerging …

Disclosed herein is a system and method for increasing the fidelity of measured genetic
data, for making allele calls, and for determining the state of aneuploidy, in one or a small …

Full coverage of the cost of clinical genetic testing is not always available through public or
private insurance programs, or a public healthcare system. Consequently, some patients …